[F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung …

K Watanabe, H Nomori, T Ohtsuka… - Japanese journal of …, 2006 - academic.oup.com
Objective: To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …
被引用次数：69 相关文章

F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung …

K Watanabe, H Nomori, T Ohtsuka… - … journal of clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Objective To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …

[F-18] Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA …

K Watanabe, H Nomori, T Ohtsuka, T Naruke… - Japanese Journal of …, 2006 - elibrary.ru
Objective: To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …

[F-18] Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA …

K Watanabe, H Nomori, T Ohtsuka… - … Journal of Clinical …, 2006 - search.ebscohost.com
Objective: To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …

[F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung …

K Watanabe, H Nomori, T Ohtsuka… - Japanese Journal of …, 2006 - europepmc.org
Objective To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …

[F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung …

K Watanabe, T Ohtsuka, H Nomori - Japanese Journal of Clinical …, 2006 - inis.iaea.org
[en] The objective of this study was to predict a malignant grade of lung cancer by
fluorodeoxyglucose positron emission tomography (FDG-PET) scanning, we investigated …

[F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung …

KI Watanabe, H Nomori, T Ohtsuka… - Japanese journal of …, 2006 - keio.elsevierpure.com
Objective: To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …
[PDF] researchgate.net

[PDF][PDF] Ken-ichi Watanabe1, Hiroaki Nomori2, Takashi Ohtsuka1, Tsuguo Naruke1, Akinori Ebihara1, Hideki Orikasa3

K Yamazaki, K Uno, T Kobayashi, T Goya - Jpn J Clin Oncol, 2006 - researchgate.net
Objective: To predict a malignant grade of lung cancer by fluorodeoxyglucose positron
emission tomography (FDG-PET) scanning, we investigated the correlation between FDG …

[F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung …

K Watanabe, T Ohtsuka, H Nomori - Japanese Journal of Clinical Oncology, 2006 - osti.gov
The objective of this study was to predict a malignant grade of lung cancer by
fluorodeoxyglucose positron emission tomography (FDG-PET) scanning, we investigated …

[引用][C] [F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA …

K WATANABE - Jpn J Clin Oncol., 2006 - cir.nii.ac.jp
[F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage
and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas | CiNii …